Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alaunos Therapeutics (TCRT) Preferred Dividend Payments (2016 - 2018)

Alaunos Therapeutics (TCRT) has disclosed Preferred Dividend Payments for 3 consecutive years, with $342000.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Preferred Dividend Payments fell 93.16% year-over-year to $342000.0, compared with a TTM value of $17.0 million through Dec 2018, down 10.24%, and an annual FY2018 reading of $17.0 million, down 10.24% over the prior year.
  • Preferred Dividend Payments was $342000.0 for Q4 2018 at Alaunos Therapeutics, down from $6.1 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $6.1 million in Q3 2018 and bottomed at $342000.0 in Q4 2018.
  • Average Preferred Dividend Payments over 3 years is $4.4 million, with a median of $4.9 million recorded in 2017.
  • The sharpest move saw Preferred Dividend Payments soared 36.54% in 2017, then crashed 93.16% in 2018.
  • Year by year, Preferred Dividend Payments stood at $3.6 million in 2016, then soared by 39.21% to $5.0 million in 2017, then plummeted by 93.16% to $342000.0 in 2018.
  • Business Quant data shows Preferred Dividend Payments for TCRT at $342000.0 in Q4 2018, $6.1 million in Q3 2018, and $5.5 million in Q2 2018.